Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The Asia Pacific diabetes care device market will grow strongly over the forecast period, fueled by the growing number of diabetic patients in the Asia Pacific region. However, the markets—particularly in China and India—continue to be limited by strong cost constraints that impede the uptake of higher priced products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diabetes care devices in Asia Pacific across a 10-year period.
Countries in the Asia Pacific region have varying adoption rates of insulin pumps, but there is little correlation between market and population size.
Which countries have seen the greatest adoption of insulin pumps and why?
Which market has the largest opportunity for growth?
Partnerships between companies are prevalent in the diabetes care device market.
Which companies have entered into mutually beneficial partnerships?
What products are these companies developing? What advantages will these products have over devices already on the market?
The rise in innovation and emerging technologies will impact the diabetes care device market significantly.
Which new products are entering the Asia Pacific market, and how will these launches impact the market and competitive landscapes?
In which countries will new devices launch first?
What regulatory and economic factors drive and limit the uptake of novel devices in the Asia Pacific countries?
Already a Client? Log in to access this report.
Omer Farooq Mohiuddin is a research associate within the Endoscopy Medtech Insights team at Decision Resources Group, specializing in Asia Pacific Diabetes Care Device markets. Omer holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education.